van Hulten, V. ., Driessen, J. H. M., Starup-Linde, J. K., Al-Mashhadi, Z. K., Viggers, R. ., Klungel, O. H., … van den Bergh, J. P. (2023). The associations of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors as add-on to metformin with fracture risk in patients with type 2 diabetes mellitus. Diabetes Obes Metab. http://doi.org/10.1111/dom.15220
O. Klungel
First name
O.
Middle name
H.
Last name
Klungel
Hageman, S. H., Petitjean, C. ., Pennells, L. ., Kaptoge, S. ., Pajouheshnia, R. ., Tillmann, T. ., … Dorresteijn, J. A. (2023). Improving 10-year cardiovascular risk prediction in apparently healthy people: flexible addition of risk modifiers on top of SCORE2. Eur J Prev Cardiol. http://doi.org/10.1093/eurjpc/zwad187
Hunt, N. B., Pajouheshnia, R. ., Salih, A. ., van Doorn, S. ., Souverein, P. C., Bazelier, M. T., … Gardarsdottir, H. . (2023). Prescribing of Low-dose Rivaroxaban in Patients with Atherosclerotic Cardiovascular Disease in the United Kingdom and the Netherlands. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.15708
van Dalem, J. ., Werkman, C. ., van den Bergh, J. P., Rossi, B. ., Viggers, R. ., Eastell, R. ., … Driessen, H. . (2022). "Use of sodium-glucose co-transporter 2 inhibitors, changes in body mass index and risk of fracture: a population-based cohort study". Diabetes Res Clin Pract, 109993. http://doi.org/10.1016/j.diabres.2022.109993
Leung, M. W., Bazelier, M. T., Souverein, P. C., Uitdehaag, B. M., Klungel, O. H., Leufkens, H. G., & Pajouheshnia, R. . (2022). Mapping the risk of infections in patients with multiple sclerosis: A multi-database study in the United Kingdom Clinical Practice Research Datalink GOLD and Aurum. Mult Scler, 13524585221094218. http://doi.org/10.1177/13524585221094218
van Veelen, A. ., Abtahi, S. ., Souverein, P. ., Driessen, J. H. M., Klungel, O. H., Dingemans, A. C., … Croes, S. . (2022). Characteristics of patients with lung cancer in clinical practice and their potential eligibility for clinical trials evaluating tyrosine kinase inhibitors or immune checkpoint inhibitors. Cancer Epidemiol, 78, 102149. http://doi.org/10.1016/j.canep.2022.102149
de Jong, H. J., Klungel, O. H., van Dijk, L. ., Vandebriel, R. J., Leufkens, H. G., van der Laan, J. W., … Van Loveren, H. . (2012). Use of statins is associated with an increased risk of rheumatoid arthritis. Ann Rheum Dis. http://doi.org/10.1136/ard.2011.155622
van den Ham, H. A., Klungel, O. H., Leufkens, H. G., & van Staa, T. P. (2013). The patterns of anticoagulation control and the risk of stroke, bleeding and mortality in patients with non-valvular atrial fibrillation. J Thromb Haemost. http://doi.org/10.1111/jth.12041
Abbing-Karahagopian, V. ., Huerta, C. ., Souverein, P. C., de Abajo, F. ., Leufkens, H. G., Slattery, J. ., … De Bruin, M. L. (2014). Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications. Eur J Clin Pharmacol. http://doi.org/10.1007/s00228-014-1676-z
Abbing-Karahagopian, V. ., Kurz, X. ., de Vries, F. ., van Staa, T. P., Alvarez, Y. ., Hesse, U. ., … Klungel, O. H. (2014). Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project. Curr Clin Pharmacol.